The advent of thrombolytic therapy initiated the era of pharmacologic reperfusion in the acute phase of myocardial infarction (MI). Although it was a major improvement in the treatment of acute MI ...

Rochester, MN - Starting a 72-hour infusion of nesiritide (Natrecor, Scios/Johnson & Johnson) after successful MI reperfusion therapy apparently suppressed aldosterone levels and may have had a ...

Ischemic heart disease is the leading cause of death globally, causing approximately 9 million deaths annually. Currently, reperfusion therapy (such as thrombolysis or interventional procedures) is ...

Mesenchymal stromal cells (MSCs) were cultured on microcarriers in 3D rotating bioreactors and primed with ginsenoside Rg1 to enhance cell proliferation. Artificial cell-derived vesicles (ACDVs) from ...

Alternative model systems to study ischemia-reperfusion are needed to support a wide range of disease-related investigations in the life sciences. Ischemia and reperfusion are relevant to many disease ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...